Literature DB >> 12911715

Rodent models for ovarian cancer research.

K D Sloan Stakleff1, V E Von Gruenigen.   

Abstract

Animal models that are biologically and clinically relevant are essential for conducting research to investigate the pathophysiologic progression of disease and to develop diagnostic or therapeutic strategies. Several rodent models that vary in methods of induction allow appropriate in vivo evaluation for ovarian cancer. The types of rodent models discussed include chemically (nonhormonal and hormonal) induced, genetic (knockout and transgenic), xenograft, and syngeneic. A summary of the available rodent models is provided with a discussion of the advantages and disadvantages of each. Optimization and application of these rodent models to future research may benefit the detection and treatment of ovarian cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12911715     DOI: 10.1046/j.1525-1438.2003.13317.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  21 in total

1.  Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.

Authors:  Zeng B Zhu; Angel A Rivera; Sharmila K Makhija; Baogen Lu; Minghui Wang; Miiru Izumi; Robert J Cerfolio; Mariam A Stoff-Khalili; Fen Zhou; Koichi Takayama; Gene P Siegal; David T Curiel
Journal:  Lung Cancer       Date:  2006-11-17       Impact factor: 5.705

2.  Immunotherapy in new pre-clinical models of HPV-associated oral cancers.

Authors:  Francesca Paolini; Silvia Massa; Isabella Manni; Rosella Franconi; Aldo Venuti
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

3.  Contrast-enhanced sonography depicts spontaneous ovarian cancer at early stages in a preclinical animal model.

Authors:  Animesh Barua; Pincas Bitterman; Janice M Bahr; Sanjib Basu; Eyal Sheiner; Michael J Bradaric; Dale B Hales; Judith L Luborsky; Jacques S Abramowicz
Journal:  J Ultrasound Med       Date:  2011-03       Impact factor: 2.153

4.  Assessment of acridine orange and SYTO 16 for in vivo imaging of the peritoneal tissues in mice.

Authors:  J A Udovich; D G Besselsen; A F Gmitro
Journal:  J Microsc       Date:  2009-05       Impact factor: 1.758

5.  Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer.

Authors:  Animesh Barua; Pincas Bitterman; Jacques S Abramowicz; Angela L Dirks; Janice M Bahr; Dale B Hales; Michael J Bradaric; Seby L Edassery; Jacob Rotmensch; Judith L Luborsky
Journal:  Int J Gynecol Cancer       Date:  2009-05       Impact factor: 3.437

6.  Prevalence of antitumor antibodies in laying hen model of human ovarian cancer.

Authors:  Animesh Barua; Seby L Edassery; Pincas Bitterman; Jacques S Abramowicz; Angela L Dirks; Janice M Bahr; Dale B Hales; Michael J Bradaric; Judith L Luborsky
Journal:  Int J Gynecol Cancer       Date:  2009-05       Impact factor: 3.437

7.  Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure.

Authors:  P B Hoyer; J R Davis; J B Bedrnicek; S L Marion; P J Christian; J K Barton; M A Brewer
Journal:  Gynecol Oncol       Date:  2009-01-16       Impact factor: 5.482

8.  Detection of tumor-associated neoangiogenesis by Doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer.

Authors:  Animesh Barua; Pincas Bitterman; Janice M Bahr; Michael J Bradaric; Dale B Hales; Judith L Luborsky; Jacques S Abramowicz
Journal:  J Ultrasound Med       Date:  2010-02       Impact factor: 2.153

9.  Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.

Authors:  Doris R Siwak; Mark Carey; Bryan T Hennessy; Catherine T Nguyen; Mollianne J McGahren Murray; Laura Nolden; Gordon B Mills
Journal:  J Oncol       Date:  2009-11-19       Impact factor: 4.375

10.  SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer.

Authors:  Whasun Lim; Hee Seung Kim; Wooyoung Jeong; Suzie E Ahn; Jinyoung Kim; Yong Beom Kim; Min A Kim; Mi-Kyung Kim; Hyun Hoon Chung; Yong Sang Song; Fuller W Bazer; Jae Yong Han; Gwonhwa Song
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.